Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of bioactive molecules targeting central nervous system disorders. Its structure supports the design of enzyme inhibitors and receptor modulators due to the presence of the oxadiazole ring, which enhances metabolic stability and binding affinity. Commonly employed in medicinal chemistry for constructing drug candidates with improved pharmacokinetic properties. Also utilized in research settings to explore structure-activity relationships in heterocyclic compound libraries.